Stephen Willey
Stock Analyst at Stifel
(3.99)
# 565
Out of 5,149 analysts
132
Total ratings
45.83%
Success rate
14.04%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Stephen Willey
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ZYME Zymeworks | Maintains: Buy | $40 → $47 | $23.96 | +96.16% | 8 | Mar 3, 2026 | |
| ACLX Arcellx | Downgrades: Hold | $127 → $115 | $114.20 | +0.70% | 2 | Feb 24, 2026 | |
| IRON Disc Medicine | Maintains: Buy | $125 → $110 | $64.41 | +70.79% | 2 | Feb 17, 2026 | |
| INCY Incyte | Maintains: Buy | $119 → $120 | $98.53 | +21.79% | 8 | Feb 11, 2026 | |
| EXEL Exelixis | Maintains: Hold | $43 → $44 | $40.63 | +8.29% | 20 | Feb 11, 2026 | |
| NRIX Nurix Therapeutics | Maintains: Buy | $33 → $35 | $15.55 | +125.08% | 6 | Jan 29, 2026 | |
| CELC Celcuity | Maintains: Buy | $68 → $115 | $106.69 | +7.79% | 2 | Nov 13, 2025 | |
| NKTX Nkarta | Maintains: Buy | $12 → $11 | $2.56 | +329.69% | 5 | Nov 11, 2025 | |
| XFOR X4 Pharmaceuticals | Maintains: Buy | $30 → $9 | $3.42 | +163.16% | 3 | Aug 29, 2025 | |
| INSM Insmed | Maintains: Buy | $121 → $145 | $147.38 | -1.61% | 8 | Aug 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $8 → $7 | $3.71 | +88.93% | 7 | Aug 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $28 | $10.82 | +158.90% | 1 | Jun 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $6 → $5 | $1.84 | +171.74% | 4 | May 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $25 → $20 | $4.53 | +341.50% | 4 | May 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $240 → $100 | $15.26 | +555.31% | 5 | Mar 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $8 → $4 | $1.46 | +174.91% | 3 | Feb 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $47 | $18.00 | +161.11% | 1 | Oct 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $8 → $4 | $0.29 | +1,276.23% | 7 | Aug 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $3 → $4 | $2.09 | +91.85% | 1 | Dec 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $53 → $62 | $43.08 | +43.92% | 5 | Dec 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $9 | $5.53 | +62.90% | 1 | Jan 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $12 | $1.71 | +601.75% | 1 | Nov 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $228 → $288 | $1.71 | +16,742.11% | 4 | Jun 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $22 → $21 | $2.17 | +869.98% | 2 | Mar 17, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $10 → $4 | $1.62 | +147.68% | 7 | Jul 29, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $125 → $123 | $321.36 | -61.73% | 3 | Aug 13, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $48 → $47 | $79.65 | -40.99% | 2 | Aug 8, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $102 → $109 | $58.71 | +85.66% | 3 | Aug 3, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Terminates: Hold | n/a | $22.30 | - | 2 | Jun 25, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $20 → $23 | $7.49 | +207.08% | 5 | Feb 7, 2018 |
Zymeworks
Mar 3, 2026
Maintains: Buy
Price Target: $40 → $47
Current: $23.96
Upside: +96.16%
Arcellx
Feb 24, 2026
Downgrades: Hold
Price Target: $127 → $115
Current: $114.20
Upside: +0.70%
Disc Medicine
Feb 17, 2026
Maintains: Buy
Price Target: $125 → $110
Current: $64.41
Upside: +70.79%
Incyte
Feb 11, 2026
Maintains: Buy
Price Target: $119 → $120
Current: $98.53
Upside: +21.79%
Exelixis
Feb 11, 2026
Maintains: Hold
Price Target: $43 → $44
Current: $40.63
Upside: +8.29%
Nurix Therapeutics
Jan 29, 2026
Maintains: Buy
Price Target: $33 → $35
Current: $15.55
Upside: +125.08%
Celcuity
Nov 13, 2025
Maintains: Buy
Price Target: $68 → $115
Current: $106.69
Upside: +7.79%
Nkarta
Nov 11, 2025
Maintains: Buy
Price Target: $12 → $11
Current: $2.56
Upside: +329.69%
X4 Pharmaceuticals
Aug 29, 2025
Maintains: Buy
Price Target: $30 → $9
Current: $3.42
Upside: +163.16%
Insmed
Aug 14, 2025
Maintains: Buy
Price Target: $121 → $145
Current: $147.38
Upside: -1.61%
Aug 8, 2025
Maintains: Buy
Price Target: $8 → $7
Current: $3.71
Upside: +88.93%
Jun 25, 2025
Initiates: Buy
Price Target: $28
Current: $10.82
Upside: +158.90%
May 14, 2025
Maintains: Hold
Price Target: $6 → $5
Current: $1.84
Upside: +171.74%
May 13, 2025
Maintains: Hold
Price Target: $25 → $20
Current: $4.53
Upside: +341.50%
Mar 21, 2025
Maintains: Buy
Price Target: $240 → $100
Current: $15.26
Upside: +555.31%
Feb 27, 2025
Maintains: Buy
Price Target: $8 → $4
Current: $1.46
Upside: +174.91%
Oct 8, 2024
Initiates: Buy
Price Target: $47
Current: $18.00
Upside: +161.11%
Aug 20, 2024
Maintains: Buy
Price Target: $8 → $4
Current: $0.29
Upside: +1,276.23%
Dec 19, 2023
Maintains: Buy
Price Target: $3 → $4
Current: $2.09
Upside: +91.85%
Dec 18, 2023
Maintains: Buy
Price Target: $53 → $62
Current: $43.08
Upside: +43.92%
Jan 27, 2023
Initiates: Buy
Price Target: $9
Current: $5.53
Upside: +62.90%
Nov 28, 2022
Initiates: Buy
Price Target: $12
Current: $1.71
Upside: +601.75%
Jun 26, 2020
Downgrades: Hold
Price Target: $228 → $288
Current: $1.71
Upside: +16,742.11%
Mar 17, 2020
Maintains: Buy
Price Target: $22 → $21
Current: $2.17
Upside: +869.98%
Jul 29, 2019
Downgrades: Hold
Price Target: $10 → $4
Current: $1.62
Upside: +147.68%
Aug 13, 2018
Maintains: Buy
Price Target: $125 → $123
Current: $321.36
Upside: -61.73%
Aug 8, 2018
Maintains: Hold
Price Target: $48 → $47
Current: $79.65
Upside: -40.99%
Aug 3, 2018
Maintains: Buy
Price Target: $102 → $109
Current: $58.71
Upside: +85.66%
Jun 25, 2018
Terminates: Hold
Price Target: n/a
Current: $22.30
Upside: -
Feb 7, 2018
Maintains: Buy
Price Target: $20 → $23
Current: $7.49
Upside: +207.08%